1. Home
  2. TARS vs SHOO Comparison

TARS vs SHOO Comparison

Compare TARS & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$60.71

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$43.13

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
SHOO
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
TARS
SHOO
Price
$60.71
$43.13
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$89.00
$42.14
AVG Volume (30 Days)
614.2K
968.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.27%
EPS Growth
48.21
N/A
EPS
N/A
1.00
Revenue
$451,360,000.00
$2,534,109,000.00
Revenue This Year
$56.43
$12.39
Revenue Next Year
$30.19
$5.90
P/E Ratio
N/A
$42.78
Revenue Growth
146.71
11.00
52 Week Low
$38.51
$22.26
52 Week High
$85.25
$46.88

Technical Indicators

Market Signals
Indicator
TARS
SHOO
Relative Strength Index (RSI) 41.92 69.70
Support Level $60.38 $43.03
Resistance Level $67.24 $44.99
Average True Range (ATR) 3.45 1.47
MACD 0.03 0.38
Stochastic Oscillator 34.38 91.70

Price Performance

Historical Comparison
TARS
SHOO

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

Share on Social Networks: